Skip to Content
Merck
  • Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2012-06-23)
Jorge A Zavala, Renato P Munhoz, Hélio A G Teive
ABSTRACT

Pramipexole is a non-ergot dopamine agonist that is used frequently as a single therapy or in combination for the management of Parkinson's disease. Common side effects are daytime drowsiness, hypotension, hallucinations and compulsive behaviour. We describe a patient who developed severe chronic and extensive lymphoedema after pramipexole was introduced and that resolved after its cessation.

MATERIALS
Product Number
Brand
Product Description

Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)